A. Laurell

One course of adjuvant BEP in clinical stage I nonseminoma mature and expanded results from the SWENOTECA group

Torgrim Tandstad, O. Ståhl, Ulf Håkansson et al. · Annals of Oncology · 2014 · 154 citations · Full text

Clinical Stage, Medicine, Immunodeficiencies +5

Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA)

Torgrim Tandstad, O. Ståhl, O. Dahl et al. · Annals of Oncology · 2016 · 137 citations

Risk-adapted Recommendations, Adjuvant Carboplatin, Urology +9

The G(-248)A polymorphism in the promoter region of the Bax gene does not correlate with prognostic markers or overall survival in chronic lymphocytic leukemia

Å Skogsberg, Gerard Tobin, Alexander Kröber et al. · Leukemia · 2005 · 36 citations

Hematological Malignancy, Oncology, Promoter Region +10

Estimating demand for potential disease-modifying therapies for Alzheimer's disease in the UK

A. Laurell, Ashwin Venkataraman, Tatjana Schmidt et al. · The British Journal of Psychiatry · 2024 · 25 citations · Full text